Global Prostate Biopsy Needle Market Size By Type (Reusable Devices, Disposable Devices), By Application (Hospitals, Ambulatory Surgical Center (ASCs)), By Region, And Segment Forecasts, 2023 to 2032

The Global Prostate Biopsy Needle Market was valued at USD 786.2 million in 2023 and is projected to reach USD 1,247.6 million by 2031, growing at a CAGR of 6.0% during the forecast period from 2023 to 2031. The market is experiencing substantial growth due to the rising prevalence of prostate cancer, increasing awareness of early cancer diagnosis, and advancements in biopsy technologies. Prostate biopsy needles are essential tools in diagnostic procedures, enabling the collection of tissue samples for histopathological examination, thus supporting accurate and early detection of prostate cancer.

Drivers:

1. Increasing Incidence of Prostate Cancer:

With prostate cancer ranking among the most common cancers in men globally, there is a heightened demand for reliable diagnostic tools, including biopsy needles, to facilitate early detection and improve survival rates.

2. Advancements in Imaging and Biopsy Guidance Systems:

Technological advancements such as MRI-ultrasound fusion-guided biopsy are significantly enhancing the accuracy and precision of prostate biopsies, propelling the demand for high-performance biopsy needles.

3. Rising Geriatric Population:

Aging is a significant risk factor for prostate cancer. The growing elderly population worldwide is driving the need for effective diagnostic solutions, including prostate biopsy devices.

Restraints:

1. Procedural Risks and Complications:

Prostate biopsies can lead to side effects such as infection, bleeding, and urinary complications, which may deter patients and affect the uptake of biopsy procedures.

2. Availability of Alternative Diagnostic Tools:

Emerging non-invasive screening methods and biomarker-based diagnostics may reduce the dependency on traditional biopsy procedures in the future.

Opportunity:

1. Expanding Access to Healthcare in Emerging Economies:

Increasing healthcare infrastructure and awareness in developing countries are creating growth opportunities for prostate biopsy needle manufacturers.

2. Integration with Robotic-Assisted Systems:

The integration of biopsy needles with robotic-assisted platforms is opening new avenues for precision diagnostics, reducing procedural errors and enhancing outcomes.

Market by System Type Insights:

Based on system type, the Disposable Prostate Biopsy Needle segment accounted for the largest market share in 2023. The single-use nature of disposable needles reduces the risk of cross-contamination, aligns with infection control protocols, and is preferred in both hospitals and diagnostic labs.

Meanwhile, the Reusable Prostate Biopsy Needle segment is expected to witness moderate growth, particularly in cost-sensitive markets and facilities with sterilization capabilities.

Market by End-use Insights:

In terms of end-use, the Hospitals segment dominated the market in 2023, contributing more than 50% of the revenue share. Hospitals provide comprehensive diagnostic facilities and are equipped with the necessary imaging technologies for accurate biopsy guidance.

The Diagnostic Centers segment is also anticipated to grow rapidly during the forecast period, driven by the increasing demand for outpatient diagnostic services and cost-effective biopsy procedures.

Market by Regional Insights:

Geographically, North America led the global prostate biopsy needle market in 2023, supported by high awareness levels, widespread adoption of advanced diagnostic technologies, and favorable reimbursement scenarios.

Asia-Pacific is projected to be the fastest-growing region, owing to a large geriatric population base, rising prostate cancer incidence, and significant improvements in healthcare infrastructure across countries like China, India, and Japan.

Competitive Scenario:

Key players in the Global Prostate Biopsy Needle Market include:

Becton, Dickinson and Company (BD)

Argon Medical Devices, Inc.

Cook Medical

Boston Scientific Corporation

Olympus Corporation

INRAD Inc.

Cardinal Health

UROMED Kurt Drews KG

Sterylab S.r.l.

DTR Medical Ltd.

These companies are focusing on innovation, strategic collaborations, and expansion into emerging markets. For example:

In 2024, BD launched a new line of precision biopsy needles compatible with MRI fusion-guided platforms to enhance diagnostic accuracy.

Olympus Corporation expanded its urology portfolio by introducing high-definition visualization biopsy kits in Asia-Pacific in 2023.

Scope of Work – Global Prostate Biopsy Needle Market

Report Metric Details

Market Size (2023) USD 786.2 million

Projected Market Size (2031) USD 1,247.6 million

CAGR (2023–2031) 6.0%

Market Segments By System Type, End-use, Region

Growth Drivers Rising prostate cancer incidence, imaging integration

Opportunities Robotic-assisted biopsies, emerging markets

Key Market Developments:

April 2024: Cook Medical announced the FDA clearance of its new high-gauge biopsy needle optimized for transperineal approaches.

August 2023: Boston Scientific completed a strategic acquisition of a startup focused on AI-powered biopsy planning tools for prostate imaging.

November 2023: Argon Medical Devices partnered with European hospitals to pilot disposable biopsy systems that reduce infection rates in high-volume settings.

FAQs:

1) What is the current market size of the Global Prostate Biopsy Needle Market?

The market was valued at USD 786.2 million in 2023.

2) What is the major growth driver of the Global Prostate Biopsy Needle Market?

The major driver is the rising incidence of prostate cancer and the growing adoption of image-guided diagnostic tools.

3) Which is the largest region during the forecast period in the Global Prostate Biopsy Needle Market?

North America is the largest region, supported by technological advancements and favorable reimbursement.

4) Which segment accounted for the largest market share in the Global Prostate Biopsy Needle Market?

The Disposable Prostate Biopsy Needle segment held the largest market share in 2023.

5) Who are the key market players in the Global Prostate Biopsy Needle Market?

Key players include BD, Argon Medical, Cook Medical, Boston Scientific, Olympus, and Cardinal Health.